CFX Logo

CFX Stock Forecast: Colfax Corp Price Predictions for 2025

Home โ€บ Stocks โ€บ United States | NYSE | |

$39.18

-0.22 (-0.56%)

CFX Stock Forecast 2025-2026

$39.18
Current Price
$2.11B
Market Cap
0 Ratings
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings

Distance to CFX Price Targets

N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A

CFX Price Momentum

-0.4%
1 Week Change
+2.8%
1 Month Change
-37.3%
1 Year Change
-10.7%
Year-to-Date Change
-37.6%
From 52W High of $62.79
+11.5%
From 52W Low of $35.14
๐Ÿ“‰ MARKET SELLOFF ALERT

10 Quality Stocks Worth Considering Now

Researching Colfax (CFX) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.

Get our FREE market selloff report + exclusive analysis on CFX and similar high-potential opportunities.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Latest CFX Stock Price Targets & Analyst Predictions

CFX has shown a year-to-date change of -10.7% and a 1-year change of -37.3%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for CFX. Please refer to the price chart above for recent performance and trends.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

CFX Analyst Ratings

0
Buy
0
Hold
0
Sell

CFX Price Target Range

Low
N/A
Average
N/A
High
N/A
Current: $39.18

Latest CFX Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for CFX.

Date Firm Analyst Rating Change Price Target

Colfax Corp (CFX) Competitors

The following stocks are similar to Colfax based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Colfax Corp (CFX) Financial Data

Colfax Corp has a market capitalization of $2.11B with a P/E ratio of 28.6x. The company generates $3.85B in trailing twelve-month revenue with a 41.9% profit margin.

Revenue growth is +0.0% quarter-over-quarter, while maintaining an operating margin of N/A and return on equity of +97.9%.

Valuation Metrics

Market Cap $2.11B
Enterprise Value $3.66B
P/E Ratio 28.6x
PEG Ratio 0.0x
Price/Sales 0.5x

Growth & Margins

Revenue Growth (YoY) +0.0%
Gross Margin +42.0%
Operating Margin N/A
Net Margin +41.9%
EPS Growth +16.4%

Financial Health

Cash/Price Ratio 0.0%
Current Ratio 2.2x
Debt/Equity 50.4x
ROE +97.9%
ROA +2.3%
๐Ÿ’ฐ DON'T MISS THIS OPPORTUNITY

Get All 10 Quality Stocks For This Market Selloff

Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.

Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Colfax Corp logo

Colfax Corp (CFX) Business Model

About Colfax Corp

What They Do

Business Model

Additional Information

Company Information

Sector

Industry

Employees

0

CEO

Country

United States

IPO Year

2008

Colfax Corp (CFX) Latest News & Analysis

CFX stock latest news image
Quick Summary

Enovis Corporation (NYSE: ENOV) completed its separation from ESAB Corporation (NYSE: ESAB), creating an independent company. Enovis also executed a one-for-three reverse stock split.

Why It Matters

Enovis's separation from ESAB creates two distinct investment opportunities, potentially enhancing growth prospects and value for shareholders in the medical tech sector.

Source: GlobeNewsWire
Market Sentiment: Neutral
CFX stock latest news image
Quick Summary

ESAB Corp. (NYSE: ESAB) will join the S&P MidCap 400 on April 5, 2022. PROG Holdings Inc. (NYSE: PRG) will replace Fiesta Restaurant Group Inc. (NASD: FRGI) in the S&P SmallCap 600 on April 6.

Why It Matters

ESAB's addition to the S&P MidCap 400 may boost its stock price due to increased visibility and demand from index funds. Changes in the SmallCap 600 can impact PROG and Fiesta's valuations.

Source: PRNewsWire
Market Sentiment: Neutral
CFX stock latest news image
Quick Summary

Colfax Corporation will be renamed Enovis Corporation after a spin-off of its fabrication technology business, which will operate as ESAB Corporation. The spin-off is expected on April 4, 2022.

Why It Matters

The spin-off of Colfax Corporation into Enovis and ESAB may create focused investment opportunities, potentially enhancing shareholder value and operational efficiency for both entities.

Source: GlobeNewsWire
Market Sentiment: Neutral
CFX stock latest news image
Quick Summary

Colfax (CFX) reported earnings 30 days ago; investors may want to monitor upcoming developments and market responses for future stock performance.

Why It Matters

Colfax's recent earnings report indicates potential stock performance trends, crucial for investors assessing future growth, valuation, and market sentiment.

Source: Zacks Investment Research
Market Sentiment: Negative
CFX stock latest news image
Quick Summary

KeyBanc lowered Colfax Corp's price target to $52 from $60, reflecting lower peer multiples, but maintains an Overweight rating. The target suggests a potential upside of 41%.

Why It Matters

Colfax Corp's lowered price target signals potential volatility, while the maintained Overweight rating suggests confidence in long-term growth, affecting investment strategies and sentiment.

Source: Benzinga
Market Sentiment: Negative
CFX stock latest news image
Quick Summary

Colfax Corporation will distribute 90% of ESAB Corporation's stock to shareholders on April 4, 2022, with a one-for-three reverse stock split occurring afterward. Colfax will retain 10% of ESAB shares.

Why It Matters

Colfax's distribution of ESAB shares alters shareholder equity and introduces potential volatility. The reverse stock split may impact share price perception and liquidity, influencing investment decisions.

Source: GlobeNewsWire
Market Sentiment: Neutral

Frequently Asked Questions About CFX Stock

What is Colfax Corp's (CFX) stock forecast for 2025?

Analyst forecasts for Colfax Corp (CFX) are not currently available. The stock is trading at $39.18.

Is CFX stock a good investment in 2025?

Analyst ratings for CFX are not currently available. The stock is currently trading at $39.18. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.

What is the long-term price prediction for CFX stock?

Price predictions from Wall Street analysts for CFX are not currently available. The stock is trading at $39.18.

What is Colfax Corp's business model?

N/A

What is the highest forecasted price for CFX Colfax Corp?

Price targets from Wall Street analysts for CFX are not currently available. The stock is trading at $39.18.

What is the lowest forecasted price for CFX Colfax Corp?

Price targets from Wall Street analysts for CFX are not currently available. The stock is trading at $39.18.

What is the overall CFX consensus from analysts for Colfax Corp?

Analyst ratings for CFX are not currently available. The stock is trading at $39.18.

How accurate are CFX stock price projections?

Stock price projections, including those for Colfax Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.

Important Disclaimer

The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Last updated: March 27, 2025 10:36 AM UTC